Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liver Neoplasms × Phlebotomy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 4 Lung Neoplasms 4 Breast Neoplasms 3 Lymphoma 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Adenocarcinoma 2 Urticaria 1 Tuberous Sclerosis 1 Thrombosis 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Severe Combined Immunodeficiency 1 Sarcoma 1 Salivary Gland Neoplasms 1 Renal Insufficiency, Chronic 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Dysautonomias 1 Polycythemia Vera 1 Polycythemia 1 Polycystic Ovary Syndrome 1 Pancreatitis, Chronic 1 Pancreatitis 1 Pancreatic Cyst 1 Ovarian Neoplasms 1

Interventions

Sorafenib 38 Oxaliplatin 21 Bevacizumab 21 Radiosurgery 15 Fluorouracil 15 Gemcitabine 14 Nivolumab 11 Hepatectomy 11 Cisplatin 11 lenvatinib 10 Radiotherapy 10 Radiofrequency Ablation 9 Leucovorin 9 Doxorubicin 9 durvalumab 8 Liver Transplantation 8 Blood Specimen Collection 8 atezolizumab 7 Capecitabine 7 pembrolizumab 6 camrelizumab 6 Immunohistochemistry 6 Everolimus 6 Electroporation 6 Cyclophosphamide 6 Cryosurgery 6 tremelimumab 5 sintilimab 5 apatinib 5 Sunitinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02548910 2021-03-18

PRICE

Ottawa Hospital Research Institute

Phase NA Completed

62 enrolled 13 charts

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡